NASDAQ:AYLA
Delisted
Ayala Pharmaceuticals Inc Stock News
$0.504
+0 (+0%)
At Close: Apr 17, 2023
Ayala Pharmaceuticals Presents Poster on AL102 in Desmoid Tumors at the Connective Tissue Oncology Society (CTOS) 2022 Annual Meeting
01:00pm, Thursday, 17'th Nov 2022 GlobeNewswire Inc.
REHOVOT, Israel and WILMINGTON, Del., Nov. 17, 2022 (GLOBE NEWSWIRE) -- Ayala Pharmaceuticals, Inc. (Nasdaq: AYLA), a clinical-stage oncology company focused on developing and commercializing small
Benzinga's Top Ratings Upgrades, Downgrades For October 31, 2022
02:13pm, Monday, 31'st Oct 2022 Benzinga
Upgrades
Morgan Stanley upgraded the previous rating for Pure Storage Inc (NYSE:PSTG) from Equal-Weight to Overweight. In the second quarter, Pure Storage showed an EPS of $0.32, compared to $0.14 fr
Benzinga's Top Ratings Upgrades, Downgrades For October 20, 2022
02:03pm, Thursday, 20'th Oct 2022 Benzinga
Upgrades
According to Credit Suisse, the prior rating for Hudson Pacific Properties Inc (NYSE:HPP) was changed from Underperform to Neutral. Hudson Pacific Properties earned $0.51 in the second quarte
AutoZone To Rise Over 9%? Plus Roth Capital Slashes PT On This Stock By 96%
12:15pm, Thursday, 20'th Oct 2022 Benzinga
Raymond James raised the price target on AutoZone, Inc. (NYSE: AZO) from $2,350 to $2,500. AutoZone shares fell 0.7% to close at $2,289.80 on Wednesday.
Roth Capital cut Ayala Pharmaceuticals, Inc
Why Olaplex Shares Dipped Around 57%; Here Are 75 Biggest Movers From Yesterday
05:52am, Thursday, 20'th Oct 2022 Benzinga
Gainers
Amprius Technologies, Inc. (NYSE: AMPX) jumped 77.3% to settle at $11.01 on Wednesday after the company announced it was awarded a $50 million cost-sharing grant from the U.S. Department of E
Why United Airlines Shares Are Trading Higher? Here Are 43 Stocks Moving In Wednesday's Mid-Day Session
04:30pm, Wednesday, 19'th Oct 2022 Benzinga
Gainers
SenesTech, Inc. (NASDAQ: SNES) shares jumped 102.6% to $0.47 after declining over 3% on Tuesday. SenesTech, during August, posted a Q2 loss of $0.21 per share.
Scopus BioPharma Inc. (NASDAQ:
Ayala Pharmaceuticals and Advaxis Enter into Merger Agreement
10:30am, Wednesday, 19'th Oct 2022 GlobeNewswire Inc.
Merger brings U.S. management and presence, cash to develop compelling late-stage asset
AYLA Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Ayala Pharmaceuticals, Inc. Is Fair to Shareholders
08:56am, Wednesday, 19'th Oct 2022
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Ayala Pharmaceuticals, Inc. (NASDAQ: AYLA) and Advaxis, Inc. is fair to Ayala sharehold
Why NLS Pharmaceutics Shares Dipped Over 23%; Here Are 67 Biggest Movers From Yesterday
09:10am, Wednesday, 28'th Sep 2022 Benzinga
Gainers
Avenue Therapeutics, Inc. (NASDAQ: ATXI) shares climbed 106.3% to close at $9.15. Avenue Therapeutics recently received the official meeting minutes from the FDA regarding a meeting conducte
Corcept (CORT) Up More Than 20% in Past 3 Months: Here's Why
06:10pm, Wednesday, 14'th Sep 2022 Zacks Investment Research
Corcept's (CORT) Cushing's syndrome drug, Korlym, is witnessing higher sales and a strong uptake since its approval. Other pipeline candidates are also advancing well.
Ayala Pharmaceuticals, Inc. (AYLA) Upgraded to Buy: Here's Why
04:00pm, Tuesday, 13'th Sep 2022 Zacks Investment Research
Ayala Pharmaceuticals, Inc. (AYLA) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Ayala Pharmaceuticals, Inc. (AYLA) Upgraded to Buy: Here's Why
01:32pm, Tuesday, 13'th Sep 2022
Ayala Pharmaceuticals, Inc. (AYLA) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Why Tuesday Morning Shares Tumbled 31%; Here Are 66 Biggest Movers From Yesterday
09:14am, Tuesday, 13'th Sep 2022 Benzinga
Gainers
NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) jumped 101.3% to settle at $0.5558 on Monday after the company announced a 1-for-30 reverse stock split.
InMed Pharmaceuticals Inc. (NASDAQ: INM)
Why Ventyx Biosciences Is Trading Higher By 70%, Here Are 46 Stocks Moving In Monday's Mid-Day Session
04:45pm, Monday, 12'th Sep 2022 Benzinga
Gainers
Ventyx Biosciences, Inc. (NASDAQ: VTYX) shares jumped 70.4% to $39.37 after Oppenheimer maintained an Outperform rating on the stock and raised its price target from $40 to $65.
NeuroBo Phar
Why Zumiez Is Trading Lower By 14%; Here Are 20 Stocks Moving Premarket
10:35am, Friday, 09'th Sep 2022 Benzinga
Gainers
Infobird Co., Ltd (NASDAQ: IFBD) rose 70.8% to $3.16 in pre-market trading after 1:5 reverse stock split takes effect.
Digital Media Solutions, Inc. (NYSE: DMS) shares rose 62.5% to $2.08 in